Home | Business News | Browse by Publication | P | PR Newswire

Janssen Pharmaceutica Products, L.P. to Appeal U.S. District Court Decision on SPORANOX(R) (itraconazole) Patent.

Publication: PR Newswire
Publication Date: 29-JUL-04
Format: Online
Delivery: Immediate Online Access

Article Excerpt
TITUSVILLE, N.J., July 29 /PRNewswire/ -- Janssen Pharmaceutica Products, L.P. will appeal a U.S. District Court decision received late yesterday in New York that found Eon Labs Manufacturing Corporation, Inc. does not infringe Janssen's patent on SPORANOX (itraconazole) capsules.

The suit had been initiated by Janssen in April 2001...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
ATF Provides Support to Children's Games., July 29, 2004
Deborah Lollar to Lead VITAS Innovative Hospice Care(R) of Dallas., July 29, 2004
NAMI Names Michael J. Fitzpatrick as New National Director., July 29, 2004
DTE Energy Deploying Plateau 4 LMS Enterprise-wide to Support Learning..., July 29, 2004
WebSurveyor Expands Marketing Team; Marketing Veterans Janet Driscoll ..., July 29, 2004

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.